TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

WHO to take call on Covaxin on Oct 6

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Hyderabad, September 19

Advertisement

The Strategic Advisory Group of Experts on Immunisation (SAGE) of the World Health Organisation would be meeting on October 6 to make its recommendations on Bharat Biotech’s Covid-19 vaccine Covaxin on emergency use listing.

Advertisement

Bharat Biotech is expected to give a presentation on the vaccine’s safety and efficacy data of clinical trials (phase 1-3 trial results and post marketing) and risk management plans and other implementation considerations, according to the SAGE draft agenda.

SAGE is authorised with advising the WHO on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. Hanna Nohynek, member of SAGE, will be presenting a draft recommendation for the vaccine and the session will make its recommendations. The session will thoroughly discuss the clinical data on Covaxin from phase 1, 2, 3 trials and post marketing studies on safety, immunogenicity, efficacy and effectiveness. — PTI

Advertisement
Advertisement
Show comments
Advertisement